Home > Animal Health & Nutrition > Veterinary Pharmaceuticals > Veterinary Intravenous (IV) Solutions Market

Veterinary Intravenous (IV) Solutions Market Share

Report ID: GMI10452
Published Date: Jul 2024
Report Format: PDF

Download Free Sample

Veterinary Intravenous Solutions Market Share

The VI solutions industry is characterized by a diverse competitive landscape, with key players vying for market share through product innovation, strategic partnerships, and geographical expansions. Companies such as Zoetis Inc., B. Braun, Hospira, and Merck & Co., Inc. are among the leading market participants, leveraging extensive product portfolios and strong distribution networks to maintain their competitive edge. These companies focus on continuous research and development to introduce novel products catering to specific veterinary healthcare needs.

Veterinary Intravenous Solutions Companies

Prominent players operating in the veterinary intravenous (IV) solutions industry include:

B. Braun Melsungen AG
Ceva Santé Animale
Dechra Pharmaceuticals plc
Elanco Animal Health
Fresenius Kabi
Hospira (Pfizer Inc.)
Jorgensen Laboratories, LLC
Merck & Co. Inc.
Sykes Vet International Pty Ltd.
Zoetis, Inc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global veterinary intravenous (IV) solutions industry was valued at USD 1.5 billion in 2023 and is anticipated to register 8% CAGR between 2024 and 2032, driven by advancements in veterinary medicine and increase in pet adoption and spending on pet healthcare.

The hospitals & clinics segment in the market is expected to reach USD 1.7 billion by 2032 due to high patient volumes, advanced equipment, and skilled staff driving IV therapy utilization.

North America veterinary intravenous solutions market is expected to reach USD 1.2 billion by 2032, fueled by the rising chronic diseases in pets requiring intensive IV management.

B. Braun Melsungen AG, Ceva Santé Animale, Dechra Pharmaceuticals plc, Elanco Animal Health, Fresenius Kabi, Hospira (Pfizer Inc.), Jorgensen Laboratories, LLC, Merck & Co. Inc., Sykes Vet International Pty Ltd., and Zoetis, Inc.